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ABSTRACT 
Objective: To develop an accurate, simple, rapid, precise, economic and stability indicating RP-HPLC method for the simultaneous estimation of 
dosulepin hydrochloride and methylcobalamin in tablet dosage form and validate as per ICH guidelines.  
Methods: The column used was Kromasil C18 (250 X 4.6 mm, 5 µm), with a mobile phase containing acetonitrile: phosphate buffer pH 3 adjusted 
with o-phosphoric acid (60:40) with a flow rate of 1 ml/min. The effluents obtained were monitored at 285 nm with photodiode array detector. 
Dosulepin hydrochloride and methylcobalamin were subjected to stress degradation conditions like hydrolysis (acid and base), oxidation, thermal 
and photolysis degradation. The samples subjected to stress degradation were analysed by the developed method. 
Results: The retention time for dosulepin hydrochloride and methylcobalamin was found to be 7.99 min and 1.97 min, respectively. The linearity of 
developed method was achieved in the range of 165-495 μg/ml for dosulepin hydrochloride and 5-15 μg/ml for methylcobalamin. The detection 
(LOD) and quantitation (LOQ) limits were found to be 0.75 µg/ml and 2.28 µg/ml for dosulepin hydrochloride and 0.040 µg/ml and 0.121 µg/ml for 
methylcobalamin respectively. In the stability studies, it was observed that there is no interference of the degradation products with drug samples. 
Conclusion: An accurate simple, rapid, precise, linear and stability indicating RP-HPLC method was developed for simultaneous quantitative 
estimation of dosulepin hydrochloride and methylcobalamin both in bulk and pharmaceutical formulation. The method was validated as per ICH 
guidelines. This method holds good for the routine analysis of dosulepin hydrochloride and methylcobalamin in various pharmaceutical industries 
as well as in academics. 
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Dosulepin hydrochloride (fig. 1) chemically is 1-Propanamine, 3-
dibenzo [b, e] thiepin-11(6H)-ylidene-N,N-dimethyl-, hydrochloride. 
Dosulepin belongs to the category of drugs referred to as tricyclic 
antidepressants and having anxiolytic properties. Dosulepin works 
by preventing serotonin and noradrenaline from being reabsorbed 
back into the nerve cells in the brain. This helps prolong the mood 
lightening effect of any released noradrenaline and serotonin. In this 
way, dosulepin helps relieve depression [1]. 
 
 
Fig. 1: Chemical structure of dosulepin hydrochloride [2] 
 
Methylcobalamin chemically is alpha-(5,6-dimethylbenzimidazolyl) 
methylcobalamin (fig. 2). It is a form of vitamin B12(cyanocobalamin) and 
differs from that the cyanide is replaced by a methyl group. Vitamin B12 is 
an essential material for the growth, cell reproduction, hematopoiesis 
and synthesis of genetic material like nucleoprotein and myelin. 
Cobalamin is generally used in the treatment of peripheral 
neuropathy, diabetic neuropathy and as a preliminary treatment 
for amyotrophic lateral sclerosis. Cobalamin is necessary for DNA 
synthesis, the formation of red blood cells and maintenance of the 
nervous system, growth and development of children [3-5].  
 
Fig. 2: Chemical structure of methylcobalamin [6] 
 
Combination therapy of dosulepin hydrochloride and 
methylcobalamin is used for the treatment of neuropathic pain. 
In literature, various spectrophotometric methods and RP-HPLC 
methods have been reported for quantitation of dosulepin 
hydrochloride and methylcobalamin in individual and combined 
available market formulation [1, 7-16]. But only one assay has been 
reported for the stability of the same [17]. The present study focuses 
on developing a new stability assay method for dosulepin 
hydrochloride and methylcobalamin in combination. This method 
will provide new insight into the stability studies of this 
combination. Moreover, this novel validated method (as per ICH 
guidelines [18-19]) has applicability in industry as well as academia.  
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MATERIALS AND METHODS  
Pharmaceutical grade dosulepin hydrochloride was procured from 
Elite Pharmaceutical Private Limited, Ahmedabad and 
methylcobalamin was obtained from Aum Laboratories, Ahmedabad. 
The marketed formulation Prothiaden M containing dosulepin 
hydrochloride 50 mg and methylcobalamin 1500 mcg was 
purchased from the local market. Methanol, orthophosphoric acid, 
acetonitrile and HPLC grade water were obtained from Merck. All 
solvents used were HPLC grade. RP-HPLC Shimadzu (LC 20ATVP) 
model with Spin chrome (LC Solutions) software was employed in 
this method. Analytical column used for the separation of analytes 
was Kromasil C18 (250 X 4.6 mm, 5 µm). 
Methods  
Selection of wavelength  
Standard solutions of dosulepin hydrochloride and methylcobalamin 
were prepared at the concentration of 10 μg/ml and scanned using 
UV-Visible spectrophotometer at the range of 200-400 nm. The 
isosbestic point selected for simultaneous estimation was 285 nm 
based on combined UV spectrums of dosulepin hydrochloride and 
methylcobalamin (fig. 3). 
Chromatographic conditions  
The developed method used a reverse phase, Kromasil C18 column 
(250 X 4.6 mm, 5 µm). The mobile phase used was acetonitrile: 
phosphate buffer pH 3 adjusted with o-phosphoric acid (60:40) at a 
flow rate of 1.0 ml/min and a detection wavelength of 285 nm using 
a photodiode array detector. 
Preparation of phosphate buffer  
Accurately weighed 2.7 g of potassium dihydrogen phosphate 
(KH2PO4) and 6 ml of triethylamine were dissolved in 800 ml of 
water; the pH was adjusted to 3.0 with o-phosphoric acid and final 
volume adjusted to 1000 ml with water. The buffer was filtered to 
remove all fine undissolved particles. 
 
 
Fig. 3: UV overlap spectrum of dosulepin hydrochloride and methylcobalamin 
 
Preparation of mobile phase  
A mixture of 60 volumes of acetonitrile and 40 volumes of phosphate 
buffer was prepared. The mobile phase was sonicated for 10 min to 
remove gases.  
Preparation of standard solutions  
A standard stock solution of dosulepin hydrochloride was prepared 
by dissolving 330 mg of dosulepin hydrochloride in 10 ml of mobile 
phase. After that, the solution was filtered and sonicated for 5 min 
and volume adjusted to 100 ml with mobile phase giving a final 
concentration of 3300 µg/ml. Similarly, a standard stock solution of 
methylcobalamin was prepared by dissolving 10 mg of 
methylcobalamin in 10 ml of mobile phase and the solution was 
filtered, sonicated for 5 min. The final concentration of 100 µg/ml 
was achieved by adjusting the volume to 100 ml. 
Sample preparation  
Twenty tablets were weighed and finely powdered. The powder 
equivalent to 330 mg dosulepin hydrochloride and 10 mg 
methylcobalamin was accurately weighed. This powder was transferred 
to the volumetric flask of 100 ml capacity and dissolved in 50 ml of 
mobile phase. The flask was sonicated for 10 min. The flask was shaken 
and volume was made up to the mark with the mobile phase. The above 
solution was filtered through Whatman filter paper (0.45μ). This 
solution is expected to contain 3300 μg/ml of dosulepin hydrochloride 
and 100 μg/ml methylcobalamin. The same solution was used for the 
estimation of dosulepin hydrochloride and methylcobalamin. 
Stress degradation studies  
Forced degradation studies were performed to know the 
degradation products and to establish degradation pathway for 
dosulepin hydrochloride and methylcobalamin. The study involves 
acid hydrolysis wherein sample solution was treated with 0.1 M HCl 
at room temperature for 24 h. The sample solution was treated with 
0.1 M NaOH at room temperature for 24 h to study alkali hydrolysis. 
Oxidative degradation studies involved 3% H2O2 treatment of sample 
solution at room temperature for 24 h. The samples were placed in hot 
air oven at 105 °C for 6 h to study thermal degradation. For photolytic 
stress studies, samples were exposed to sunlight for 7 d [19]. 
RESULTS AND DISCUSSION  
Method development  
Different chromatographic conditions were tried for better 
separation and resolution. Kromasil C18 (250 X 4.6 mm, 5 µm) 
column was found satisfactory. Peak purity of dosulepin 
hydrochloride and methylcobalamin was checked using photodiode 
array detector and wavelength of 285 nm was considered 
satisfactory for detecting both the drugs with adequate sensitivity. A 
variety of solvents in different ratios over a wide range of pH were 
tried, but either peak shape was broad or resolution was not good. 
Repeated trials were performed in order to obtain good, sharp peak 
with an efficient resolution between two peaks of dosulepin 
hydrochloride and methylcobalamin. This was achieved by 
performing isocratic HPLC on a C18 column. The run time was 12 min 
in an isocratic trial with the use of mobile phase consisting of 
acetonitrile: phosphate buffer pH 3.0 (60:40) on a Kromasil C18 
(250×4.6 mm, 5 μm) column with flow rate 1.0 ml/min and 
detection wavelength 285 nm. This developed method gave 
satisfactory results in terms of retention time, resolution, symmetry 
and sensitivity. A typical RP-HPLC chromatogram for simultaneous 
determination of dosulepin hydrochloride and methylcobalamin 
from the standard can be seen in fig. 4. 
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Fig. 4: Typical chromatogram of standard solution 
 
Method validation  
The developed RP-HPLC method was validated for parameters like 
system suitability, linearity, accuracy, precision, limit of detection 
(LOD), limit of quantitation (LOQ) and robustness according to ICH 
guidelines [18-19]. 
System suitability  
Standard solutions were prepared as per the test method and 
injected into the chromatographic system. The system suitability 
parameters like theoretical plates, resolution and tailing factor were 
evaluated. The system suitability parameters were tabulated in table 
1. All the parameters were found to be within the limits [20-21]. 
Linearity  
The linearity of the method was determined by assaying dosulepin 
hydrochloride and methylcobalamin standard stock solution at five 
different concentrations. Concentrations of dosulepin hydrochloride 
taken were 165, 247.5, 330, 412.5 and 495 μg/ml and for 
methylcobalamin 5, 7.5, 10, 12.5 and 15 μg/ml. The calibration 
curves were plotted between the responses of peak area versus 
concentration of the analyte. Least-squares linear regression 
analysis was performed for the calibration curves (fig. 5 and 6). The 
results have shown an excellent correlation between peak areas and 
concentration within the concentration range of 165–495 μg/ml for 
dosulepin hydrochloride, 5–15 μg/ml for methylcobalamin (table 2). 
The correlation coefficients were found to be 0.999 for dosulepin 
hydrochloride and 0.994 for methylcobalamin, which meet the 
method validation acceptance criteria [20-21] and hence the method 
was said to be linear for both the drugs. 
Precision  
The precision of the method was verified by two various methods-
repeatability and reproducibility (intraday and interday precision) 
 
Table 1: Results of system suitability studies 
Parameters Acceptance limits Dosulepin hydrochloride Methylcobalamin 
Retention time - 7.991 1.972 
Theoretical plates NLT 2000 2770 2344 
Tailing factor (T) NMT 2 1.736 1.298 
Resolution NLT 2 9.55 9.55 
#NLT: Not less than. # NMT: Not more than 
 
 
Fig. 5: Linearity chart for dosulepin hydrochloride 
 
Fig. 6: Linearity chart for methylcobalamin
 
Table 2: Linearity data for dosulepin hydrochloride and methylcobalamin 
Parameters Dosulepin hydrochloride Methylcobalamin 
Linearity range (μg/ml) 165-495 5-15 
Regression equation y = 9853. x-13428 y = 17225x-8572 
Correlation coefficient 0.999 0.994 
Average %RSD (Peak area, n=5) (Linearity) 0.16 0.39 
# n: Number of injections for liniarity= 5, # %RSD: Relative standard deviation 
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Repeatability  
The sample solution was prepared at working concentration of 330 
μg/ml for dosulepin hydrochloride and 10 μg/ml for methylcobalamin as 
described earlier. Repeatability analysis was carried out by injecting the 
sample 6 times for the same concentration of both the drugs. The results 
of repeatability study are provided in table 3. 
The method was found to be precise as the % RSD values calculated 
were within the limits for repeatability [20-21]. 
Reproducibility (intraday and interday precision) 
Intraday and interday precision were carried out using three 
replicates of different concentrations (165, 330 and 495 μg/ml for 
dosulepin hydrochloride; 5, 10 and 15 μg/ml for 
methylcobalamin). The results of intraday and interday precision 
are tabulated in table 4.  
The method was found to be precise as the % RSD values calculated 
were within the limits for reproducibility [20-21]. 
 
Table 3: Repeatability data for dosulepin hydrochloride and methylcobalamin 
Concentration of dosulepin 
hydrochloride 
















Mean 2868471 Mean 246198 
SD 26493.98 SD 2210.877 
%RSD 0.92 %RSD 0.89 
# n: Number of injections= 6, # SD: Standard deviation, # %RSD: Relative standard deviation 
 
Table 4: Intraday and interday precision data for dosulepin hydrochloride and methylcobalamin 
Drug Concentration 
(µg/ml) 
Intra-day precision Intra-day precision 
mean±SD (n=3) % RSD mean±SD (n=3) %  RSD 
Dosulepin hydrochloride 165 1475903±3817 0.25 1499656±20976 1.39 
330 3075762±14929 0.48 3125024±42235 1.35 
495 4714408±19769 0.41 4731060±57485 1.21 
Methylcobalamin 5 77230±645 0.84 77273±1183 1.53 
10 157826±978 0.62 156792±2612 1.66 
15 253929±1337 0.52 254524±4647 1.82 
# n: Number of injections= 3, # SD: Standard deviation, # %RSD: Relative standard deviation 
 
Accuracy  
The accuracy of the method was determined by recovery studies. 
The percent mean recovery of both the drugs at three different 
levels (50 %, 100 % and 150%) was determined. The recovery 
studies were performed in triplicates for each level. The percentage 
recovery and mean percentage recovery calculated for the drug is 
shown in table 5. The observed data were within the required range 
[20-21], which indicates good recovery values, affirming the 
accuracy of the method developed. 
  
Table 5: Results of accuracy 
Drug Level (%) (n=3) Amount taken (µg/ml) Amount recovered (mean±SD) % Recovery 
Dosulepin  
hydrochloride 
50 165 164.64±1.196 99.78 
100 330 327.56±1.659 99.26 
150 495 495.03±3.673 99.98 
Methylcobalamin 50 5 4.995±0.056 99.96 
100 10 9.92±0.027 99.21 
150 15 15.081±0.149 100.56 
#n: Number of injections= 3, #SD: Standard deviation  
 
Robustness  
To determine the robustness of the developed method, experimental 
conditions were deliberately altered, and the system suitability 
parameter retention time and peak area were evaluated. The 
solutions prepared as per the test method described earlier and 
injected at different variable conditions like flow rate (0.8, 1, 1.2 
ml/min.), mobile phase ratio of acetonitrile and phosphate buffer 
(59:41, 60:40, 61:39) and pH (2.8, 3, 3.2). The assessments of system 
suitability parameter like retention time and peak area were 
compared with that of method precision. The method was found to 
be precise as the % RSD values calculated were within the limits for 
robustness [20-21] indicating method was robust. Robustness data 
are given in table 6. 
Limit of detection (LOD) and Limit of quantitation (LOQ)  
LOD and LOQ were determined using the formulas, LOD = 3.3×SD/S 
and LOQ = 10×SD/S, where, ‘SD’ is the standard deviation of the 
response and ‘S’ is the slope of the calibration curve. The LOD and LOQ 
values were found to be 0.75 μg/ml and 2.28/μg/ml for dosulepin 
hydrochloride and 0.040 μg/ml and 0.121 μg/ml for methylcobalamin.
 
Shah et al. 
Int J App Pharm, Vol 9, Issue 4, 2017, 69-75 
73 
Table 6: Robustness study for dosulepin hydrochloride and methylcobalamin 
Parameter Method condition Dosulepin hydrochloride Methylcobalamin 
Retention time Peak area Retention time Peak area 
Flow rate (ml/min) 0.8 8.002 3030254 1.993 154856 
1.0 7.991 3088441 1.972 157257 
1.2 7.921 3091163 1.956 159635 
%RSD 0.55 1.12 0.9 1.51 
Mobile phase ratio-acetonitrile: phosphate buffer 59:41 7.958 3046672 1.966 153563 
60:40 7.991 3088441 1.972 157257 
61:39 8.006 3093753 1.994 155209 
%RSD 0.31 0.83 0.74 1.19 
pH 2.8 7.969 3092528 1.963 156843 
3.0 7.991 3088441 1.972 157257 
3.2 7.948 3074510 1.983 154621 
%RSD 0.26 0.30 0.51 0.91 
#% RSD: Relative standard deviation 
 
Forced degradation studies  
Forced degradation studies were performed to demonstrate the 
stability of the sample in different stressed conditions. The 
conditions used were acid and base hydrolysis, dry heat, oxidation 
and sunlight photolysis. The acid hydrolysis showed little 
degradation of dosulepin hydrochloride and methylcobalamin with 
degraded products peaks at retention time 7.223 and 2.903. For 
alkali degradation, degraded product peak was observed at 
retention time 6.957 and 3.543. Degradation studies under oxidative 
conditions gave degraded product peaks at retention time 6.943 and 
3.867. For the thermal degradation, peaks were observed at 
retention time 7.497 and 2.790 for degraded products. In 
photohydrolysis, degraded product peaks were observed at 
retention time 9.447 and 2.737.  
The data for forced degradation are tabulated in table 7. There was 
no interference of any peak at the retention time of analytes from 
the blank. RP-HPLC chromatograms for degradation of dosulepin 
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Fig. 7: Representative chromatograms of acid (A), base (B), oxidative (C), thermal (D), and photolytic (E) degradation of dosulepin 
hydrochloride and methylcobalamin 
 
Table 7: Forced degradation data 
S. No. Condition applied % degradation 
Dosulepin hydrochloride Methylcobalamin 
1 0.1 M HCl 26.39% 22.71% 
2 0.1 M NaOH 22.59% 22.51% 
3 3 % H2O2 28.56% 34.30% 
4 Heat treatment 32.48% 29.72% 
5 Photolysis 36.40% 38.20% 
 
In previous report [17] dosulepin hydrochloride and methylcobalamin 
were assayed using Inertsil-ODS (250x4.6 mm, 5 μm) column with 
mobile phase containing 0.02 % orthophosphoric acid and methanol 
(400:600 v/v), whereas this study uses a novel column, Kromasil C18 
(250×4.6 mm, 5 μm) column with novel mobile phase consisting of 
acetonitrile: phosphate buffer pH 3.0 (60:40) wherein retention time 
of 1.972 for methylcobalamin and 7.991 for dosulepin hydrochloride 
with better resolution is found. Moreover, various reports of assaying 
these compounds alone or in other combinations exist but the method 
developed in this report is first of its kind.  
CONCLUSION  
The proposed study, a new stability-indicating RP-HPLC method has 
been developed for estimation of dosulepin hydrochloride and 
methylcobalamin in bulk and pharmaceutical dosage form. The 
developed method was validated and it was found to be simple, 
sensitive, precise, and robust and it can be used for the routine 
analysis of dosulepin hydrochloride and methylcobalamin in both 
bulk and pharmaceutical dosage forms. The forced degradation 
studies were carried out in accordance with ICH guidelines and the 
results revealed suitability of the method to study the stability of 
dosulepin hydrochloride and methylcobalamin under various 
degradation conditions like acid, base, oxidative, thermal, and 
photolytic degradations. Finally, it was concluded that the method is 
simple, sensitive and has the ability to separate the drug from 
degradation products and excipients found in the dosage form. 
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